Company Overview of Lysosomal Therapeutics Inc.
Lysosomal Therapeutics Inc. is engaged in small-molecule research and development in the field of neurodegenerative diseases to discover new drugs for patients with severe neurological diseases. The company provides services to target Gaucher-related neurodegeneration, Parkinson’s disease, and other synucleinopathies. Lysosomal Therapeutics Inc. was incorporated in 2011 and is headquartered in Cambridge, Massachusetts.
19 Blackstone Street
Cambridge, MA 02139
Founded in 2011
Key Executives for Lysosomal Therapeutics Inc.
Lysosomal Therapeutics Inc. Key Developments
Similar Private Companies By Industry
|Dios Therapeutics, Inc.||United States|
|Audentes Therapeutics, Inc.||United States|
|Biomira USA Inc.||United States|
|Palmera Holdings, Inc.||United States|
|King Pharmaceuticals Research & Development Inc.||United States|
Recent Private Companies Transactions
April 30, 2014
To contact Lysosomal Therapeutics Inc., please visit www.lysosomaltx.com. Company data is provided by Capital IQ. Please use this form to report any data issues.